- Home
- GRDN vs BCAT Comparison
GRDN vs BCAT Comparison
Compare GRDN & BCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRDN
- BCAT
- Stock Information
- Founded
- GRDN 2004
- BCAT 2020
- Country
- GRDN United States
- BCAT United States
- Employees
- GRDN N/A
- BCAT N/A
- Industry
- GRDN Retail-Drug Stores and Proprietary Stores
- BCAT Finance/Investors Services
- Sector
- GRDN Consumer Staples
- BCAT Finance
- Exchange
- GRDN Nasdaq
- BCAT Nasdaq
- Market Cap
- GRDN 1.8B
- BCAT 1.5B
- IPO Year
- GRDN 2024
- BCAT N/A
- Fundamental
- Price
- GRDN $27.24
- BCAT $14.70
- Analyst Decision
- GRDN Strong Buy
- BCAT
- Analyst Count
- GRDN 2
- BCAT 0
- Target Price
- GRDN $24.50
- BCAT N/A
- AVG Volume (30 Days)
- GRDN 345.7K
- BCAT 308.8K
- Earning Date
- GRDN 11-11-2025
- BCAT 01-01-0001
- Dividend Yield
- GRDN N/A
- BCAT 9.38%
- EPS Growth
- GRDN N/A
- BCAT N/A
- EPS
- GRDN N/A
- BCAT 1.43
- Revenue
- GRDN $1,326,604,000.00
- BCAT N/A
- Revenue This Year
- GRDN $16.17
- BCAT N/A
- Revenue Next Year
- GRDN $2.31
- BCAT N/A
- P/E Ratio
- GRDN N/A
- BCAT $11.41
- Revenue Growth
- GRDN 18.53
- BCAT N/A
- 52 Week Low
- GRDN $14.16
- BCAT $13.67
- 52 Week High
- GRDN $30.39
- BCAT $16.38
- Technical
- Relative Strength Index (RSI)
- GRDN 54.36
- BCAT 38.82
- Support Level
- GRDN $27.35
- BCAT $14.90
- Resistance Level
- GRDN $30.39
- BCAT $15.29
- Average True Range (ATR)
- GRDN 1.16
- BCAT 0.11
- MACD
- GRDN -0.09
- BCAT -0.01
- Stochastic Oscillator
- GRDN 40.47
- BCAT 3.28
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
About BCAT BlackRock Capital Allocation Term Trust of Beneficial Interest
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.